UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000034132
Receipt number R000038912
Scientific Title A study to compare the absorbency after food intake containing plant extract for adult males (1)
Date of disclosure of the study information 2019/09/15
Last modified on 2018/12/13 16:33:42

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A study to compare the absorbency after food intake containing plant extract for adult males (1)

Acronym

A study to compare the absorbency after food intake containing plant extract (1)

Scientific Title

A study to compare the absorbency after food intake containing plant extract for adult males (1)

Scientific Title:Acronym

A study to compare the absorbency after food intake containing plant extract (1)

Region

Japan


Condition

Condition

Healthy adult

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To compare the absorbency of two types of plant extract containing food for healthy adult males

Basic objectives2

Bio-availability

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

AUC
Cmax

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

Single intake of test food A- single intake of test food B

Interventions/Control_2

Single intake of test food B- single intake of test food A

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

60 years-old >=

Gender

Male

Key inclusion criteria

Healthy males aged 20-60 years

Key exclusion criteria

(1) Subjects having possibilities for emerging allergy related to the study.
(2) Subjects who are under medication.
(3) Subjects who are under treatment or have a history of serious disease(e.g., diabetes, liver disease, kidney disease, or heart disease).
(4) Subjects who are judged as unsuitable for the study based on the results of lifestyle questionnaire.
(5) Subjects who constantly take in supplement richly containing licorice extract.
(6) Subjects who are judged as unsuitable for the study based on the results of clinical and physical examination at the screening.
(7) Subjects who have habits affecting research results, such as doing shift work day and night, or Subjects who have a plan that affect research results such as day and night shift work or going overseas.
(8) Subjects who have participated in other clinical study within the last one month prior to the current study.
(9) Subjects who are difficult to take the test food as instructed.
(10) Subjects who donated over 200 ml of blood at least one month before the test started.
(11) Subjects who have experience of bad mood or deteriorating physical condition due to blood collection.
(12) Subjects who are judged as unsuitable for the study by the investigator for other reason.

Target sample size

24


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yo Miyakoshi

Organization

KANEKA CORPORATION

Division name

Pharma & Supplemental Nutrition Solutions Vehicle

Zip code


Address

1-12-32, Akasaka, Minato-ku, Tokyo

TEL

050-3133-9895

Email

Yo.Miyakoshi@kaneka.co.jp


Public contact

Name of contact person

1st name
Middle name
Last name Shingo Yamamichi

Organization

TTC Co.,Ltd

Division name

Clinical Research Planning Department

Zip code


Address

Seibu Shinkin Bank Ebisu Bldg.,1-20-2, Ebisunishi, Shibuya-ku, Tokyo

TEL

03-5459-5329

Homepage URL


Email

s.yamamichi@ttc-tokyo.co.jp


Sponsor or person

Institute

TTC Co., Ltd

Institute

Department

Personal name



Funding Source

Organization

KANEKA CORPORATION

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2019 Year 09 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2018 Year 09 Month 13 Day

Date of IRB


Anticipated trial start date

2018 Year 09 Month 18 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2018 Year 09 Month 14 Day

Last modified on

2018 Year 12 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000038912


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name